# A green-electrospun nanofibrous scaffold incorporating polyethylenimine-modified liposomes for sustained BMP2 gene delivery and enhanced osteogenic differentiation

**Authors:** Lin Zhang, Mengxia Chen, Zhen Chen, Sunfei Chen, Shenghan Duan, Shuqi Lou, Hongsheng Wang

PMC · DOI: 10.3389/fbioe.2026.1748649 · Frontiers in Bioengineering and Biotechnology · 2026-02-04

## TL;DR

A new eco-friendly scaffold for bone tissue engineering delivers BMP2 genes over time, promoting bone cell growth and mineralization.

## Contribution

A green electrospun scaffold with PEI-modified liposomes for sustained BMP2 gene delivery and enhanced osteogenic differentiation is developed.

## Key findings

- The scaffold achieved sustained pDNABmp2 release over 14 days with uniform nanocomplex integration.
- BMSCs showed improved adhesion, proliferation, and osteogenic differentiation with increased ALP activity and calcium deposition.
- The scaffold demonstrated excellent biocompatibility and efficient gene transfection in vitro.

## Abstract

Bone tissue engineering requires scaffolds that mimic the native extracellular matrix and provide sustained delivery of osteoinductive factors. This study focuses on developing a multifunctional scaffold using a green electrospinning process to combine the biocompatibility of silk fibroin (SF) with a non‐viral gene delivery system for sustained expression of Bone Morphogenetic Protein 2 (BMP2).

A green electrospinning technique, using an aqueous SF and polyethylene oxide (PEO) solution, was employed to fabricate nanofibrous scaffolds, eliminating the use of harsh organic solvents. Polyethylenimine (PEI) modified liposomes (LipoPEI) were used to encapsulate a BMP2‐encoding plasmid (pDNA
Bmp2
). These gene‐loaded nanoparticles were incorporated into the SF‐PEO nanofibers. The resulting scaffolds were characterized for morphology (SEM), structure (FTIR, XRD), and drug release kinetics. Biological performance was evaluated by assessing cell viability (MTT assay), cell attachment (SEM), gene transfection efficiency (confocal microscopy), and osteogenic differentiation (alkaline phosphatase (ALP) activity, Alizarin Red S staining) using bone marrow mesenchymal stem cells (BMSCs).

Physicochemical characterization confirmed the successful formation of uniform pDNABmp2@LipoPEI nanocomplexes with a particle size of approximately 266 nm and a positive surface charge of +16.9 mV. These nanocomplexes were homogeneously incorporated into smooth, bead-free SF‐PEO nanofibers with average diameters ranging from 460 to 541 nm. The composite scaffold demonstrated a highly sustained release of pDNABmp2 over 14 days. In vitro studies using rat bone marrow-derived mesenchymal stem cells (BMSCs) revealed that the scaffold possesses excellent biocompatibility, promoting robust cell adhesion, spreading, and proliferation. Furthermore, the gene‐loaded scaffold successfully mediated the transfection of BMSCs, leading to significant upregulation of osteogenic markers, including alkaline phosphatase (ALP) activity and extensive calcium mineral deposition over 21 days.

The novel composite scaffold combines the structural advantages of SF with a sustained BMP2 gene delivery system, showing remarkable potential to promote osteogenic differentiation. This work presents a promising, environmentally friendly, and effective platform for bone tissue engineering and regenerative medicine.

## Linked entities

- **Genes:** BMP2 (bone morphogenetic protein 2) [NCBI Gene 650]
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** collagen [NCBI Gene 693056], BMP2 (bone morphogenetic protein 2) [NCBI Gene 650] {aka BDA2, BMP2A, SSFSC, SSFSC1}, Pdlim3 (PDZ and LIM domain 3) [NCBI Gene 114108] {aka Actn2lp, Alp}, Bmp2 (bone morphogenetic protein 2) [NCBI Gene 29373], BMP2 [NCBI Gene 733059]
- **Diseases:** ectopic bone formation (MESH:D000072717), bone defect (MESH:D001847), cytotoxicity (MESH:D064420), infection (MESH:D007239), osteogenesis (MESH:D010013), tumor (MESH:D009369), pain (MESH:D010146), trauma (MESH:D014947), inflammation (MESH:D007249), congenital abnormalities (MESH:D000013)
- **Chemicals:** DMSO (MESH:D004121), ARS (MESH:C004468), LiBr (MESH:C040949), Calcium (MESH:D002118), PBS (MESH:D007854), 3,3'-dioctadecyloxacarbocyanine perchlorate (MESH:C098044), lipid (MESH:D008055), cetylpyridinium chloride (MESH:D002594), CO2 (MESH:D002245), Octadecylamine (MESH:C009317), hydroxyapatite (MESH:D017886), phosphotungstic acid (MESH:D010772), amino acids (MESH:D000596), MTT (MESH:C070243), penicillin (MESH:D010406), Amide I (-), Alizarin red (MESH:C010078), aluminum (MESH:D000535), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MESH:C022616), HFIP (MESH:C001337), ethanol (MESH:D000431), cholesterol (MESH:D002784), water (MESH:D014867), Triton X-100 (MESH:D017830), streptomycin (MESH:D013307), -PEO (MESH:D011092), PEI (MESH:D011094), formazan (MESH:D005562), gold (MESH:D006046)
- **Species:** Bombyx mori (domestic silkworm, species) [taxon 7091], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12913382/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12913382/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC12913382/full.md

---
Source: https://tomesphere.com/paper/PMC12913382